Adamas Pharmaceuticals reported 50K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Aptinyx Inc APTX:US $ 677K 0
Flexion Therapeutics FLXN:US $ 50K 0
GlaxoSmithKline GSK:LN 1347M 0M
Glaxosmithkline GSK:US $ 1347M 0M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Heron Therapeutics HRTX:US $ 1.02M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 901M 12M
Omeros OMER:US $ 625K 1000
Prothena PRTA:US $ 0.46M 0.02M
Revance Therapeutics RVNC:US $ 0.07M 0M
Teva Pharmaceutical TEVA:IT 57M 0